Influence of PI-3K/Akt pathway on Wnt signalling in regulating myeloid progenitor cell proliferation. Evidence for a role of autocrine/paracrine Wnt regulation

Br J Haematol. 2009 Sep;146(6):637-51. doi: 10.1111/j.1365-2141.2009.07823.x. Epub 2009 Jul 28.

Abstract

The regulation of myeloid progenitor cell (granulocyte-macrophage colony-forming units, CFU-GM) proliferation/differentiation by the Wnt and phosphatidylinositol-3 kinase (PI-3K) pathways was investigated using a colony-replating assay. The PI-3K pathway promoted differentiation of interleukin-3 (IL-3)-stimulated myelopoiesis via Akt, because inhibition of the PI-3K/Akt pathway with LY294002 or SH-5 increased proliferation. The involvement of canonical and non-canonical Wnt pathways was investigated using Wnt3a and Wnt5a respectively. Addition of the recombinant Wnts to IL-3 increased CFU-GM proliferation. Dkk-1, when combined with the Wnt proteins, abrogated the effects of Wnt3a but not Wnt5a. Surprisingly, the addition of Dkk-1 to LY294002 or SH-5 blocked their proliferative effects. We hypothesized that increased proliferation induced by PI-3K/Akt inhibitors was not mediated by downstream activation of the Wnt pathway but by induced endogenous production/release of Wnt proteins. The addition of SH-5 to IL-3 created an autocrine Wnt loop in CD34(+) cells, resulting in the phosphorylation of lipoprotein-receptor-related-protein 6. Furthermore, the addition of medium conditioned by CD34(+) cells cultured in IL-3 + SH-5 to IL-3 increased CFU-GM proliferation. This effect was abrogated by Dkk-1, suggesting that a Wnt in the conditioned medium increased proliferation. In summary, IL-3 via the PI-3K pathway promoted differentiation of myeloid progenitor cells through a decrease of endogenous Wnt production/release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD34
  • Cell Differentiation / drug effects*
  • Cell Proliferation / drug effects*
  • Cells, Cultured
  • Granulocyte-Macrophage Progenitor Cells / cytology*
  • Humans
  • Intercellular Signaling Peptides and Proteins / pharmacology*
  • Interleukin-3 / pharmacology*
  • Myeloid Progenitor Cells / metabolism*
  • Myelopoiesis / drug effects
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins / pharmacology
  • Signal Transduction / drug effects*
  • Wnt Proteins / pharmacology
  • Wnt-5a Protein
  • Wnt3 Protein
  • Wnt3A Protein

Substances

  • Antigens, CD34
  • DKK1 protein, human
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-3
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins
  • WNT3A protein, human
  • WNT5A protein, human
  • Wnt Proteins
  • Wnt-5a Protein
  • Wnt3 Protein
  • Wnt3A Protein